+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics CXO Services Market - Global Forecast 2026-2032- Product Image
Biologics CXO Services Market - Global Forecast 2026-2032- Product Image
New

Biologics CXO Services Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121982
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biologics CXO Services Market is rapidly evolving as scientific complexity, regulatory demands, and resilient supply strategies reshape expectations for external partners in biopharmaceutical development and manufacturing.

Market Snapshot: Biologics CXO Services Market Growth and Trends

The Biologics CXO Services Market expanded from USD 580.21 million in 2025 to USD 624.93 million in 2026 and is anticipated to reach USD 935.84 million by 2032, progressing at a CAGR of 7.06%. This growth underlines a transition across the industry: outsourcing is now fundamental to managing process intricacy, data integrity, and supply-chain resilience from early development through to global commercialization.

Scope & Segmentation

This research offers a structured perspective on the evolving shape of the Biologics CXO Services Market by dissecting key segment drivers:

  • Service Types: Integrated development and manufacturing offerings, analytical and quality support.
  • Molecule Classes: Established biologics, novel constructs including multi-specifics and fusion proteins.
  • Stages of Development: Early feasibility, late-stage, and commercial supply programs.
  • End User Groups: Emerging biotechs, mid-size sponsors, large biopharma organizations.
  • Manufacturing Scales: Small clinical batches, mid-scale, and commercial production campaigns.
  • Technologies: Platform manufacturing, single-use systems, digital batch record management, real-time process analytics.
  • Geographies: Americas, Europe, Middle East & Africa, and Asia-Pacific.

Distinct regional strengths range from process expertise and regulatory rigor in North America and Europe to emerging ecosystem development in Middle East & Africa, and expanded technical capacity and quality alignment in Asia-Pacific.

Key Takeaways for Senior Decision-Makers

  • Biologics outsourcing strategies are shifting: executive leaders increasingly embed CXO partnerships as core enterprise capabilities, emphasizing alignment across operations, quality, and data transparency.
  • Modality innovation drives demand for CXO partners with advanced analytics and deep process know-how, supporting both conventional and next-generation biologics.
  • Integrated delivery models minimize risk from fragmented supply chains—favoring providers able to deliver end-to-end solutions and harmonized documentation.
  • Digitalization, data integrity, and consistent execution now distinguish leading providers, enabling traceability and regulatory confidence throughout the product lifecycle.
  • Supply resilience and flexible sourcing are incorporated upfront in program design to mitigate raw material volatility and geopolitical uncertainty.
  • Procurement priorities and partner selection criteria diverge sharply by sponsor size, molecule complexity, development stage, and region.

Tariff Impact and Strategic Procurement Shifts

Upcoming United States tariff actions are set to influence biologics CXO strategies chiefly via increased input costs and procurement re-engineering. While direct tariffs on finished biologics may be limited, upstream inputs such as single-use systems, specialty components, and packaging will likely experience cost volatility. Organizations are adapting by diversifying supplier bases, planning for alternative vendors, and embedding dual sourcing strategies. Contractual frameworks and master service agreements now routinely address cost pass-through and material requalification protocols to ensure uninterrupted timelines and regulatory compliance.

Resilience Through Regionalization

As import delays and shifting duties create operational risk, sponsors increasingly evaluate in-region or near-shore manufacturing options, especially for commercially sensitive programs. The result is a growing emphasis on supply solutions that pair technical excellence with adaptability to changing trade policies.

Methodology & Data Sources

This report synthesizes findings from validated secondary sources, expert interviews, and triangulated analytical frameworks. Public regulatory guidance, industry disclosures, and cross-regional expert consultations ensure insights are both actionable and market-specific. Rigorous quality checks confirm the relevance and accuracy of observed trends.

Why This Report Matters

  • Provides strategic clarity for selecting resilient biologics CXO partners aligned with enterprise-wide goals.
  • Equips senior leaders to embed analytical and supply-chain readiness into program architectures from the outset, minimizing lifecycle risk exposure.
  • Helps anticipate procurement challenges amid geopolitical shifts, enabling pre-emptive risk mitigation and governance formalization.

Conclusion

Biologics CXO success increasingly hinges on execution certainty, robust supply strategies, and governance frameworks that support compliance and operational agility. Leaders who align internal teams and prioritize resilience set their organizations apart in a changing global landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biologics CXO Services Market, by Service Model
8.1. CDMO
8.1.1. Analytical Testing
8.1.2. Manufacturing
8.1.3. Process Development
8.1.4. Regulatory Consulting
8.2. CMO
8.2.1. Clinical Manufacturing
8.2.2. Commercial Manufacturing
8.3. CRO
8.3.1. Clinical Trial Management
8.3.2. Pharmacovigilance
8.3.3. Preclinical Services
9. Biologics CXO Services Market, by Therapeutic Area
9.1. Autoimmune
9.2. Cardiology
9.3. Infectious Diseases
9.4. Neurology
9.5. Oncology
10. Biologics CXO Services Market, by Clinical Stage
10.1. Commercial
10.2. Discovery
10.3. Phase I
10.4. Phase II
10.5. Phase III
10.6. Preclinical
11. Biologics CXO Services Market, by Application
11.1. Cell Therapy
11.2. Gene Therapy
11.3. Monoclonal Antibodies
11.4. Recombinant Proteins
11.5. Vaccines
12. Biologics CXO Services Market, by End User
12.1. Academia
12.2. Biopharmaceutical Companies
12.3. Research Institutions
13. Biologics CXO Services Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biologics CXO Services Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biologics CXO Services Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biologics CXO Services Market
17. China Biologics CXO Services Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AGC Biologics
18.6. AGC Inc.
18.7. Alvotech hf.
18.8. BioVectra Inc.
18.9. Boehringer Ingelheim International GmbH
18.10. Catalent, Inc.
18.11. Curia Global, Inc.
18.12. Fujifilm Holdings Corporation
18.13. Hikma Pharmaceuticals PLC
18.14. Lonza Group AG
18.15. Merck KGaA
18.16. Novasep Holding SAS
18.17. Patheon Biologics
18.18. Piramal Pharma Solutions
18.19. Polpharma Biologics
18.20. PTC Bio, Inc.
18.21. Recipharm AB
18.22. Richter-Helm Biologics GmbH & Co. KG
18.23. Samsung Biologics Co., Ltd.
18.24. Sartorius AG
18.25. Siegfried Holding AG
18.26. Thermo Fisher Scientific Inc.
18.27. Vetter Pharma International GmbH
18.28. WuXi Biologics Inc.
18.29. Xellia Pharmaceuticals A/S
List of Figures
FIGURE 1. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOLOGICS CXO SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOLOGICS CXO SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ACADEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ACADEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 142. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 143. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 144. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 145. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 146. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. EUROPE BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 160. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 161. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 162. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 163. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 164. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 179. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 180. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 181. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 182. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 183. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 184. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. ASEAN BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 188. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 189. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 190. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 191. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 192. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 193. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. GCC BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 206. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 207. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 208. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 209. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 210. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 211. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. BRICS BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 215. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 216. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 217. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 218. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 219. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 220. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. G7 BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 224. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 225. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 226. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 227. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 228. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 229. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. NATO BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
TABLE 243. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2032 (USD MILLION)
TABLE 244. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2032 (USD MILLION)
TABLE 245. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2032 (USD MILLION)
TABLE 246. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 247. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2032 (USD MILLION)
TABLE 248. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. CHINA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biologics CXO Services market report include:
  • AGC Biologics
  • AGC Inc.
  • Alvotech hf.
  • BioVectra Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Curia Global, Inc.
  • Fujifilm Holdings Corporation
  • Hikma Pharmaceuticals PLC
  • Lonza Group AG
  • Merck KGaA
  • Novasep Holding SAS
  • Patheon Biologics
  • Piramal Pharma Solutions
  • Polpharma Biologics
  • PTC Bio, Inc.
  • Recipharm AB
  • Richter‑Helm Biologics GmbH & Co. KG
  • Samsung Biologics Co., Ltd.
  • Sartorius AG
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma International GmbH
  • WuXi Biologics Inc.
  • Xellia Pharmaceuticals A/S

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 624.93 Million
Forecasted Market Value ( USD ) by 2032 $ 935.84 Million
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Biologics & Biosimilars CXO Services Market - Global Forecast 2026-2032 - Product Image

Biologics & Biosimilars CXO Services Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Inhalable Biologics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Inhalable Biologics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 132 Pages
  • Global
From
Biologics Fill Finish Manufacturing Market: Industry Trends and Global Forecasts, Till 2035 - Product Image

Biologics Fill Finish Manufacturing Market: Industry Trends and Global Forecasts, Till 2035

  • Report
  • 473 Pages
  • Global
From
Biologics Testing Service Market - Global Forecast 2025-2030 - Product Image

Biologics Testing Service Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Biologics Fill Finish Services Market Industry Trends and Global Forecasts to 2035, by Type of Primary Packaging Container, Type of Biologic Manufactured, Scale of Operation, Therapeutic Area, End-users, Type of Player and and Key Geographical Regions - Product Image

Biologics Fill Finish Services Market Industry Trends and Global Forecasts to 2035, by Type of Primary Packaging Container, Type of Biologic Manufactured, Scale of Operation, Therapeutic Area, End-users, Type of Player and and Key Geographical Regions

  • Report
  • 473 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.